CAL
SYNH

Capital Advisors Ltd’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Capital Advisors Ltd’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-27
Closed -$1K – 1755
2022
Q3 		$1K Buy
+27
New +$1.74K ﹤0.01% 1185

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Advisors Ltd's SYNH Position: Q4 2022 in Review

Capital Advisors Ltd sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 27 shares — an estimated $1K sold.

Capital Advisors Ltd first reported a position in SYNH in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

  • Capital Advisors Ltd reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Capital Advisors Ltd sold 27 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $1K.
  • Capital Advisors Ltd first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2022 and held it in 1 quarter.
  • Capital Advisors Ltd's Syneos Health, Inc. Class A Common Stock position peaked at $1K in Q3 2022.
  • 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Capital Advisors Ltd's 13F filing for Q4 2022, filed 7 Feb 2023.